| 1. |
Fillpits M, Suchomel RW, Dekan G, et al. Expression of the multidrug resistanceassociated protein (MRP) gene in colorectal carcinomas [Ｊ]. Br J Cancer, 1997; 75(2)∶208.
|
| 2. |
張立陽,趙玉沛,廖泉,等. MDR1在胰腺癌細胞株中的表達及其意義 [Ｊ]. 中華實驗外科雜志， 2003； 20（5）∶475.
|
| 3. |
Jokoby WB. Methods in enzymology [M]. New York: Acad Press,1979∶150.
|
| 4. |
Hansen MB, Nielsen SE, Berg K. Reexamination and further development of a precise and rapid dye method for measuring cell growth/cell kill [Ｊ]. J Immunol Methods, 1989; 119(2)∶203.
|
| 5. |
Biedler JL, Riehm H. Cellular resistance to actinomycin D in Chinese hamster cells in vitro: crossresistance, radioautographic, and cytogenetic studies [Ｊ]. Cancer Res, 1970; 30(4)∶1174.
|
| 6. |
Suwa H, Ohshio G, Arao S, et al. Immunohistochemical localization of Pglycoprotein and expression of the multidrug resistance1 gene in human pancreatic cancer: relevance to indicator of better prognosis [Ｊ]. Jpn J Cancer Res, 1996; 87(6)∶641.
|
| 7. |
易善紅,楊唐俊, 何斌,等. 體內基因轉移建立多藥耐藥性人膀胱癌裸鼠荷瘤模型 [Ｊ]. 中華泌尿外科雜志, 2000; 21(9)∶547.
|
| 8. |
Yu DS, Chang SY, Ma CP. Characterization and modulation of transitional cell carcinoma cell lines with acquired multidrug resistance [Ｊ]. Br J Urol, 1998; 81(2)∶234.
|
| 9. |
梁正東，卞度宏. 卵巢癌細胞對順鉑耐藥及其逆轉的實驗研究 [Ｊ]. 中華婦產科雜志，1996； 31(2)∶75.
|
| 10. |
Moran E, Cleary I, Larkin AM, et al. Coexpression of MDRassociated markers, including P170, MRP and LRP and cytoskeletal proteins, in three resistant variants of the human ovarian carcinoma cell line, OAW42 [Ｊ]. Eur J Cancer, 1997; 33(4)∶652.
|
| 11. |
UchiyamaKokubu N, Watanabe T. Establishment and characterization of adriamycinresistant human colorectal adenocarcinoma HCT15 cell lines with multidrug resistance [Ｊ]. Anticancer Drugs, 2001; 12(9)∶769.
|
